Optune (Tumor Treating Fields)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Optune (Tumor Treating Fields), covering 2023-02-02 to 2023-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma [Phase 2]